✦ LIBER ✦

Estimating the Cardiovascular Benefits of DPP-4 Inhibitors: A Simulated Study

✍ Scribed by Schuetz, C.A.; Ong, S.H.; Yeung, T.; Blüher, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular dynamic simulations reveal the

✍ Gu, Yongliang; Wang, Wei; Zhu, Xiaolei; Dong, Keke 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 991 KB

Management of a Prediabetes Case With th

✍ Johnson, J. L.; O'Neal, K. S.; Pack, C. C.; Kim, M. K. 📂 Article 📅 2014 🏛 Harvey Whitney Books Company 🌐 English ⚖ 289 KB

Cardiovascular pleiotropic actions of DP

✍ Balakumar, Pitchai; Dhanaraj, Sokkalingam A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Novel heterocyclic DPP-4 inhibitors for

✍ Jon M. Sutton; David E. Clark; Stephen J. Dunsdon; Garry Fenton; Amanda Fillmore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 444 KB

DPP-4 inhibitors and their potential rol

✍ A. BARNETT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

Sitagliptin phosphate: A DPP-4 inhibitor

✍ Tina Zerilli; Eunice Y. Pyon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 201 KB